Companies Structure Therapeutics, and Entera Bio, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market players The oral proteins & peptides market is witnessing steady growth, driven by the rising prevalence and cost of chronic diseases, advancements in drug delivery technologies, patient preference and compliance for the oral route of drug administration, and the increasing adoption of inorganic growth strategies, such as collaborations and agreements, which are reshaping the industry landscape
06 GMP ISO 9001:2015 Synthesized in a US GMP-certified, ISO 9001:2015 compliant facility
It is known that endogenous levels of GHK peptide naturally decline with age, from roughly 200 ng/ml at age 20 to 80 ng/ml at age 60 [3], and studies have shown that GHK-Cu can reset gene expression of human cells to a healthier state, which has led to breakthroughs in tissue regeneration and wound healing [4, 5, 6]
Will be interesting to watch this play out over the next year or so
Unlike traditional treatments, BPC-157 acts at the cellular level, supporting regeneration in muscles, tendons, ligaments, and even some organs
Thus, its our mission and responsibility to design and manufacture products using the highest-quality, effective, clinically tested and nature-based active ingredients
